Rivanna Medical
  • Products
    • ProductsAccuro
    • Consumables
  • Resources
    • TrainingTraining
    • Testimonials
    • Clinical Value
    • Articles & Press
    • Upgrade
  • About
    • AboutRIVANNA
    • Leadership & BOD
    • Careers
  • Contact
    • ContactContact Us
    • Return Policy
  • Get Quote
Select Page

RIVANNA to commercialize low-cost, bedside system to minimize non-diagnostic BMTB acquisition

by Vicki Brothers | May 21, 2020 | All, News, Press Releases

Palpation alone to determine the appropriate needle trajectory is recognized as a contributing factor in the acquisition of non-diagnostic BMTB specimens [1, 2].   CHARLOTTESVILLE, VA, May 20, 2020 — RIVANNA announced that the company was awarded a $1.5M research...

Recent Posts

  • 70 Birth Statistics and Facts
  • 32% Cesarean Rate Drives Demand for First-Attempt Neuraxial Success
  • Solving the Blind Procedure Problem in Modern Obstetric Anesthesia
  • RIVANNA’s 2025 Year in Review: Medical Imaging Innovation Across U.S. Healthcare
  • Global Neuraxial Practices: How Regional Differences Shape Patient Outcomes

Products


Accuro
Accuro 3S
Accessories
Consumables
True-View Phantoms

Resources


Clinical Evidence
Testimonial
Accuro Academy
Articles & Press
True-View Phantoms

Resources


Product Documents
Service & Warranty
Software Updates
Contact Us

About

RIVANNA
Technology
Mission, Vision, & Values
Leadership, BOD, & Advisory
Careers

  • Facebook
  • X
  • YouTube
  • LinkedIn
  • Instagram
Designed by ProvenContent.com © 2024 RIVANNA MEDICAL | 2400 HUNTERS WAY | CHARLOTTESVILLE, VA 22911